Concurrent chemotherapy and antibiotic use associated with epithelial ovarian cancer outcomes

Researchers at Cleveland Clinic's Ob/Gyn & Women's Health Institute and Lerner Research Institute recently published a retrospective study in Gynecologic Oncology which found that women with newly diagnosed stage III or IV epithelial ovarian cancer and received antibiotics following cytoreductive surgery and platinum chemotherapy had worse outcomes in comparison to those who did not receive antibiotics.

Cleveland Clinic's Peter G. Rose, MD, Ofer Reizes, PhD and Roberto Vargas, MD are co-authors on the study and members of the Case Comprehensive Cancer Center.

Read more from Cleveland Clinic Lerner Research Institute